Integrated Wealth Concepts LLC Sells 2,642 Shares of Haleon plc (NYSE:HLN)

Integrated Wealth Concepts LLC decreased its stake in Haleon plc (NYSE:HLN) by 13.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,608 shares of the company’s stock after selling 2,642 shares during the period. Integrated Wealth Concepts LLC’s holdings in Haleon were worth $186,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. FMR LLC increased its holdings in shares of Haleon by 5.8% during the third quarter. FMR LLC now owns 104,918,269 shares of the company’s stock worth $1,110,035,000 after buying an additional 5,768,117 shares in the last quarter. Clearbridge Investments LLC increased its holdings in Haleon by 8.6% in the 2nd quarter. Clearbridge Investments LLC now owns 41,753,987 shares of the company’s stock worth $344,888,000 after purchasing an additional 3,307,009 shares in the last quarter. Sculptor Capital LP raised its position in Haleon by 67.8% in the second quarter. Sculptor Capital LP now owns 8,887,098 shares of the company’s stock valued at $73,407,000 after purchasing an additional 3,592,000 shares during the last quarter. Envestnet Asset Management Inc. boosted its stake in shares of Haleon by 2.7% during the second quarter. Envestnet Asset Management Inc. now owns 7,572,548 shares of the company’s stock valued at $62,549,000 after purchasing an additional 196,843 shares in the last quarter. Finally, Raymond James & Associates grew its holdings in shares of Haleon by 14.7% during the second quarter. Raymond James & Associates now owns 4,019,978 shares of the company’s stock worth $33,205,000 after purchasing an additional 515,651 shares during the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Price Performance

Shares of HLN opened at $9.76 on Friday. The business has a 50-day moving average of $9.75 and a 200-day moving average of $9.51. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. The company has a market capitalization of $44.18 billion, a price-to-earnings ratio of 28.71, a price-to-earnings-growth ratio of 2.95 and a beta of 0.28. Haleon plc has a 1 year low of $7.89 and a 1 year high of $10.80.

Analyst Ratings Changes

A number of research analysts recently issued reports on HLN shares. UBS Group upgraded shares of Haleon to a “strong-buy” rating in a report on Tuesday, October 1st. Morgan Stanley raised their price target on shares of Haleon from $9.90 to $10.95 and gave the company an “overweight” rating in a research note on Friday, September 20th. One analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $10.95.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.